Company Update1 Min Read InvestyWise NewsonJanuary 31, 2026 Advanced Enzymes Lawsuit Reversed, ₹159.64 Million Provision Reversed Advanced Enzymes Technologies Ltd. has announced a favorable resolution in its lawsuit against World Nutrition Inc. The decision of the United…
Company Update2 Min Read InvestyWise NewsonJanuary 31, 2026 Birla Corporation Board Approves Extension of Key Executives’ Terms Birla Corporation’s Board of Directors has approved the extension of terms for two key senior management personnel. Shri Kalidas…
Board Meeting1 Min Read InvestyWise NewsonJanuary 31, 2026 Bharat Dynamics Board Declares Interim Dividend of ₹4.50 Per Share The Board of Directors of Bharat Dynamics Limited has declared an interim dividend of ₹4.50 per share, for the financial year 2025-26. This…
Corporate Action2 Min Read InvestyWise NewsonJanuary 31, 2026 Clean Science Board Approves Q3 FY26 Results, Declares ₹2 Interim Dividend Clean Science and Technology Limited’s board has approved the unaudited standalone and consolidated financial results for Q3 FY26,…
Company Results1 Min Read InvestyWise NewsonJanuary 31, 2026 Birla Corporation Board Approves Extension of Senior Management Terms The Board of Directors of Birla Corporation has approved the extension of terms for two senior management personnel. Shri Kalidas…
Corporate Action2 Min Read InvestyWise NewsonJanuary 31, 2026 Clean Science Board Approves Q3 Results, Declares ₹2 Interim Dividend Clean Science and Technology Limited’s board approved the unaudited standalone and consolidated financial results for Q3 FY26…
Corporate Action2 Min Read InvestyWise NewsonJanuary 31, 2026 Sun Pharma Q3FY26 Revenue Up 15.1%, Interim Dividend Declared Sun Pharmaceutical Industries reported a 15.1% YoY increase in revenue to ₹154,691 million for Q3FY26. Net profit rose by 16.0% to ₹33,688…
Board Meeting1 Min Read InvestyWise NewsonJanuary 31, 2026 Birla Corporation Board Approves Q3 Results, Extends Key Personnel Terms Birla Corporation’s Board approved the unaudited financial results for Q3 FY26, with standalone revenue at ₹1,197.94 Crores and a profit…
Company Results1 Min Read InvestyWise NewsonJanuary 31, 2026 Sun Pharma Reports Q3FY26 Results, Interim Dividend Declared Sun Pharmaceutical Industries Limited announced its Q3FY26 results with sales up by 15.1% YoY to ₹154,691 million. Net profit increased by…
Company Update2 Min Read InvestyWise NewsonJanuary 31, 2026 Clean Science Q3 FY26 Results, Hydroquinone Production Begins Clean Science and Technology Limited (CSTL) announced its Q3 FY26 results, showcasing resilient EBITDA margins amid challenging market…